Reslizumab Recombinant Human Monoclonal Antibody
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
MA541868 | 100 µg | 488,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Endotoxin level < 0.01EU/µg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt. Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab inhibits IL-5-dependent cell proliferation, with an IC50 value of approximately 91. 1pM. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4. 3 pM in the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively.
Category | Antibody |
Supplier | ThermoFisher |
Application | EL, WB |
Regulatory Status | RUO |
Immunogen | Human IL5 |
Host | Hu |
Isotype | IgG4 |
Crossreactivity | Chemical |
Clonality | Recombi |
Format | Liquid; PBS; pH 7.4, with no preservative |
Concentration | 1.71 mg/mL |
Working Dilution | Western Blot (Assay-dependent), ELISA (Assay-dependent) |
Purity | Protein A |
Conjugation | Unconjugated |
Storage Conditions | -20° C, Avoid Freeze/Thaw Cycles |
Disclaimer | Alternative CatNo: MA5-41868 |
Tech. Data Sheet | View datasheet |
Link To Supplier | https://www.thermofisher.com |
Material Safety Data Sheet | Download PDF |